freeline is a biopharmaceutical company focused on the development and commercialisation of gene therapies for bleeding and other debilitating disorders based on a next-generation aav gene therapy platform developed by amit nathwani, professor of haematolo

Freeline Therapeutics Holdings plc American Depositary Shares

Sold all FRLN

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 